Pathogenic characteristics at diagnosis in young children with type 1 diabetes presenting prior to 5 years of age.
We examined pathogenic characteristics in Japanese children with type 1 diabetes presenting before 5 years of age. The subjects were 23 Japanese children, 9 males and 14 females, 1.1-4.8 yr of age at diagnosis. The majority had severe metabolic decompensation accompanied by complete absence of β-cell function at diagnosis. We found a high frequency of preceding viral illness (41.7%) among them. The prevalence of antibodies to GAD and IA-2 at diagnosis in young children were significantly lower than those in older cases diagnosed after 5 yr of age (31.6% vs. 86.3%, 47.1% vs. 82.5%, respectively). These findings suggest that non-autoimmune mechanisms or age-related differences in autoimmunity could be involved in the pathogenesis of diabetes in young children. In regard to diabetes-related HLA-DRB1 and DQB1 alleles, all subjects had high-risk genotypes in both alleles. On the other hand, none of the patients had any of the protective genotypes in either allele. In regard to haplotypes, the frequencies of DRB1*0405-DQB1*0401 and DRB1*0901/ DQB1*0303 were 60.9% and 52.2%, respectively, and both these haplotypes are associated with strong susceptibility to type 1 diabetes. Patients with early-childhood onset may have diabetes-related autoimmunity and genetic backgrounds different from those of patients diagnosed at a later age.
Department of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
Tatsuhiko
T
Urakami
Department of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
Junichi
J
Suzuki
Department of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
Ayako
A
Yoshida
Department of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
Hiroshi
H
Saito
Department of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
Mika
M
Wada
Department of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
Shouri
S
Takahashi
Department of Pediatrics, Nihon University School of Medicine, Tokyo, Japan.
Hideo
H
Mugishima
HLA; autoantibodies; type 1 diabetes; young children